Regulus Therapeutics (NASDAQ:RGLS) Now Covered by Analysts at StockNews.com
StockNews.com began coverage on shares of Regulus Therapeutics (NASDAQ:RGLS – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also weighed in on RGLS. Canaccord Genuity Group increased their target price on Regulus Therapeutics from $9.00 to $12.00 and gave […]
More Stories
Verizon Communications Inc. (NYSE:VZ) Shares Acquired by TrinityPoint Wealth LLC
TrinityPoint Wealth LLC lifted its stake in shares of Verizon Communications Inc. (NYSE:VZ – Free Report) by 3.2% during the...
TrinityPoint Wealth LLC Purchases 75,333 Shares of Invesco BulletShares 2027 Corporate Bond ETF (NASDAQ:BSCR)
TrinityPoint Wealth LLC boosted its position in Invesco BulletShares 2027 Corporate Bond ETF (NASDAQ:BSCR – Free Report) by 75.3% during...
2,465 Shares in Novanta Inc. (NASDAQ:NOVT) Acquired by Chesapeake Capital Corp IL
Chesapeake Capital Corp IL purchased a new position in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) during the third...
Chesapeake Capital Corp IL Takes Position in Applied Digital Co. (NASDAQ:APLD)
Chesapeake Capital Corp IL acquired a new stake in Applied Digital Co. (NASDAQ:APLD – Free Report) during the 3rd quarter,...
Chesapeake Capital Corp IL Has $273,000 Stake in The Greenbrier Companies, Inc. (NYSE:GBX)
Chesapeake Capital Corp IL increased its position in shares of The Greenbrier Companies, Inc. (NYSE:GBX – Free Report) by 27.9%...
Swiss National Bank Sells 8,000 Shares of Marriott International, Inc. (NASDAQ:MAR)
Swiss National Bank decreased its position in shares of Marriott International, Inc. (NASDAQ:MAR – Free Report) by 1.1% in the...